Navigation Links
Mylan's Third Quarter 2011 Adjusted Diluted EPS Increases 28% to $0.55
Date:10/26/2011

Solution were the result of increased volume.

Gross profit for the nine months ended September 30, 2011 was $1.92 billion and gross margins were 41.7%. For the nine months ended September 30, 2010, gross profit was $1.64 billion and gross margins were 40.8%. Gross profit for the current year-to-date period is impacted by certain purchase accounting related items, of approximately $278.1 million, which consisted primarily of amortization related to purchased intangible assets associated with acquisitions. Excluding such items, gross margins would have been approximately 48%. Prior year gross profit is also impacted by similar purchase accounting related items in the amount of $217.6 million. Excluding such items, gross margins in the prior year would have been approximately 46%. This increase in gross margin is primarily the result of new product launches in North America and favorable pricing on the EpiPen® Auto-Injector.  

Earnings from operations were $758.1 million for the nine months ended September 30, 2011, compared to $627.4 million for the comparable prior year period.  Excluding the impact of purchase accounting related items in both periods, as mentioned above, earnings from operations increased to $1.04 billion in the current nine-month period from $845.0 million in the prior year comparable period, mainly due to an increase in gross profit, as a result of an increase in revenues and gross margin improvement, partially offset by increases in R&D and SG&A expense. Also included in the current nine-month period is $28.5 million of net expense related to the settlement of litigation.  In the comparable prior year period, Mylan recognized net expense from litigation settlements of $14.3 million.  

Interest expense for the nine months ended September 30, 2011, totaled $254.8 million, compared to $240.0 million for comparable prior year period. The increase is primarily due to interest as
'/>"/>

SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Sangamo BioSciences Reports Third Quarter 2011 Financial Results
2. Life Technologies Announces Third Quarter 2011 Results
3. Insmed to Host 2011 Third Quarter Earnings Conference Call
4. Cell Therapeutics, Inc. (CTI) Reports Third Quarter Financial Results and Milestones
5. Anthera Announces Third Quarter 2011 Financial Report and Conference Call
6. Pacira Pharmaceuticals, Inc. Announces Timing for Third Quarter 2011 Financial Results Webcast and Conference Call
7. Amgen’s Third Quarter 2011 Revenue and Adjusted Earnings Per Share (EPS) Each Increased 3 Percent to $3.9 Billion and $1.40
8. HeartWare Schedules Third Quarter Conference Call and Webcast
9. Dyadic International Announces Date and Time of Third Quarter 2011 Financial Results Release and Conference Call
10. United Therapeutics Corporation to Announce Third Quarter 2011 Financial Results Before Market Open on Thursday, October 27, 2011
11. Sangamo BioSciences Announces Third Quarter 2011 Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014 2013 was a banner ... State Technologies®. They saw continued independent research led by ... were awarded a $1 million grant from the Susanne ... and Behavior” a peer reviewed journal, Amy Grant highlighted ...
(Date:1/15/2014)... AudioNotch is the internet's leading provider of Notched ... tinnitus. Patients listen to sound therapy that is tailor-made ... weeks to months, their tinnitus volume decreases. , AudioNotch has ... and Notched White Noise. Now, AudioNotch is pleased to announce ...
(Date:1/14/2014)... Date: Friday, April 11, 2014 , Time: 6 ... Almshouse Road, Warrington, Pa. , Details: The Hepatitis ... finding a cure for hepatitis B and improving the quality ... Crystal Ball on Friday, April 11 at Warrington Country Club ...
(Date:1/14/2014)... San Diego, CA (PRWEB) January 14, 2014 ... based on the products of cells grown under simulated ... an international license agreement with Suneva Medical, Inc. for ... media (CCM). , This agreement is an ...
Breaking Biology Technology:Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3
... Cobent, ... coveted Brandon Hall bronze award for technology excellence in the Best Advance in Learning ... ... learning and compliance training management solutions announced today it has won a coveted Brandon ...
... Regado Biosciences, a privately held company leading the ... that Ellen McDonald , MBA, Senior Vice President and ... Convention at McCormick Place in Chicago, Illinois .  Ms. ... begin at 3:30pm, CDT and will include an ...
... HUNTINGTON BEACH, California , and ... at the 11th Annual Meeting of the American Society ... diagnostics, announced,that Breast Cancer Research and Treatment has published ... patients with a,high-risk of breast cancer recurrence according to ...
Cached Biology Technology:Cobent Wins Bronze Brandon Hall Learning Technology Award 2Cobent Wins Bronze Brandon Hall Learning Technology Award 3Regado Biosciences to Present at the BIO International Convention Held in Chicago, Illinois on May 5, 2010 2Regado Biosciences to Present at the BIO International Convention Held in Chicago, Illinois on May 5, 2010 3New Study Demonstrates Patients With High-Risk MammaPrint Profile Benefit From Chemotherapy 2New Study Demonstrates Patients With High-Risk MammaPrint Profile Benefit From Chemotherapy 3
(Date:7/9/2014)... the puzzle behind nature,s ability to split the ... the development of artificial photosynthesis for clean, green ... international collaboration of scientists led by researchers with ... the SLAC National Accelerator Laboratory. , Working ... world,s most powerful x-ray laser, the researchers were ...
(Date:7/9/2014)... of increasing concern about the prevalence of antibiotic-resistant ... promising new pathway to disabling disease: blocking bacteria,s ... scientists showed how bacterial siderophore, a small molecule, ... fan bacterial growth as well as how ... infection process. Their findings appear in a recent ...
(Date:7/9/2014)... census of Adlie penguins shows that the population ... larger than previously estimated. Adlie penguins have long ... and understand the effects of climate change and ... high-resolution satellite imagery, researchers from Stony Brook University ... method that permits regular monitoring of Adlie penguins ...
Breaking Biology News(10 mins):Postcards from the photosynthetic edge 2Postcards from the photosynthetic edge 3Bacteria hijack plentiful iron supply source to flourish 2New study finds that Adélie penguin population is on the rise 2New study finds that Adélie penguin population is on the rise 3
... to starting a business. Thats the case with 14-year-old Anshul ... card game, Elementeo, that aims to teach chemistry to students ... Meeting of the American Chemical Society in New Orleans, Samar ... play on their Xbox, this precocious CEO hopes to secure ...
... good news for pistachio fans! According to new data unveiled ... snacking on pistachios has proved once again to have a ... in the body, a prominent cardiovascular disease (CVD) risk factor. ... in the U.S., with millions more Americans currently living with ...
... scientists has resulted in an exciting new method for rapidly ... pesticides. Recently completed testing by an independent European defence ... 99 per cent effective when used on the deadly nerve ... full destruction of all three agents was achieved in less ...
Cached Biology News:14-year-old CEO makes chemistry a game with 'Elementeo' 2Nutrition research unveiled this week shows pistachios are smart for the heart 2Nutrition research unveiled this week shows pistachios are smart for the heart 3Nutrition research unveiled this week shows pistachios are smart for the heart 4Queen's develops safe 'green' decontamination method 2
Goat polyclonal to FBXO2 ( Abpromise for all tested applications). entrezGeneID: 26232 SwissProtID: Q9UK22...
Phospho-TAK1 (Thr184/187) (90C7) Rabbit mAb Shipping Temperature: Cold Storage Temperature: -20C...
Mouse monoclonal to Factor V Heavy Chain Immunogen: Purified human Factor V. Specificity: This antibody reacts with the activation C peptide (mw ~150,000) in the heavy chain of thrombin-cleave...
Gamma delta T Lymphocytes Purified Anti-Porcine clone MAC320, Isotype Rat IgG 2a , kappa, 0.1 mg Consult technical datasheet for details....
Biology Products: